|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
107,850,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Vaxcyte is a clinical-stage vaccine company. Co. is developing conjugate and protein vaccines to treat bacterial infectious diseases. Co.'s primary vaccine candidate, VAX-24, is a 24-valent investigational pneumococcal conjugate vaccine (PCV) for the treatment of invasive pneumococcal disease and pneumonia. Co.'s second PCV candidate, VAX-XP, is designed to expand the breadth of coverage to greater than 30 strains without compromising immunogenicity due to carrier suppression. In addition, Co.'s pipeline includes VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep and VAX-PG, a protein vaccine candidate targeting the keystone pathogen responsible for periodontitis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
132,527 |
297,711 |
366,947 |
577,759 |
| Total Sell Value |
$9,422,498 |
$19,561,310 |
$23,008,468 |
$28,538,885 |
| Total People Sold |
5 |
6 |
6 |
8 |
| Total Sell Transactions |
17 |
37 |
45 |
83 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lukatch Heath |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
5,625 |
|
- |
|
| Kamarck Michael E. |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
5,625 |
|
- |
|
| Gilbert Halley E |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
5,625 |
|
- |
|
| Loxam Teri |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
5,625 |
|
- |
|
| Hirth Peter |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
5,625 |
|
- |
|
| Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
• – – |
2023-06-07 |
4 |
D |
$51.25 |
$33,056 |
D/D |
(645) |
21,676 |
|
- |
|
| Wassil Jim |
Chief Operating Officer |
• – – |
2023-03-02 |
4 |
D |
$41.49 |
$49,332 |
D/D |
(1,189) |
169,026 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2023-03-02 |
4 |
D |
$41.49 |
$71,653 |
D/D |
(1,727) |
82,002 |
|
- |
|
| Pickering Grant |
Chief Executive Officer |
• • – |
2023-03-02 |
4 |
D |
$41.49 |
$128,578 |
D/D |
(3,099) |
425,252 |
|
- |
|
| Cowan Elvia |
SVP, Finance |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,250 |
7,250 |
|
- |
|
| Wassil Jim |
Chief Operating Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
170,215 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
83,729 |
|
- |
|
| Eydelman Mikhail |
SVP, Gen Counsel & Corp Sec |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,750 |
21,782 |
|
- |
|
| Pickering Grant |
Chief Executive Officer |
• • – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
53,875 |
428,351 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2023-01-10 |
4 |
AS |
$46.04 |
$14,526 |
D/D |
(315) |
3,125 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2023-01-10 |
4 |
OE |
$16.00 |
$5,040 |
D/D |
315 |
3,440 |
|
- |
|
| Pickering Grant |
Chief Executive Officer |
• • – |
2022-12-30 |
4 |
OE |
$2.03 |
$30,771 |
D/D |
15,158 |
374,476 |
|
- |
|
| Guggenhime Andrew |
President and CFO |
• – – |
2022-12-30 |
4 |
OE |
$5.35 |
$126,747 |
D/D |
23,691 |
61,229 |
|
- |
|
| Dhaliwal Harpreet S. |
SVP Cml Mfg & Supply Chain |
• – – |
2022-12-28 |
4 |
OE |
$25.06 |
$99,989 |
D/D |
3,990 |
21,808 |
|
- |
|
| Wassil Jim |
Chief Operating Officer |
• – – |
2022-12-23 |
4 |
OE |
$2.42 |
$254,998 |
D/D |
105,371 |
147,715 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2022-12-12 |
4 |
AS |
$42.37 |
$14,717 |
D/D |
(335) |
3,125 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2022-12-12 |
4 |
OE |
$16.00 |
$5,360 |
D/D |
335 |
3,460 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2022-11-10 |
4 |
AS |
$44.74 |
$199,989 |
D/D |
(4,335) |
3,125 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2022-11-10 |
4 |
OE |
$16.00 |
$69,360 |
D/D |
4,335 |
7,460 |
|
- |
|
| Lukatch Heath |
Director |
– • – |
2022-10-26 |
4 |
AS |
$38.25 |
$153,000 |
D/D |
(4,000) |
3,125 |
|
- |
|
349 Records found
|
|
Page 5 of 14 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
